Christopher D: Personalized CRISPR Therapy and the Future of Rare Disease Care
Christopher D., Executive Specialty Sales at AbbVie, shared a post on LinkedIn:
“A baby named KJ Muldoon is why I can’t stop thinking about where medicine is headed.
KJ was born with a rare genetic disorder that stopped his liver from clearing ammonia from his blood.
The old options: a transplant, or irreversible damage. Instead, his team built a personalized CRISPR therapy for his exact mutation and delivered it straight to his liver.
It worked he’s the world’s first patient treated this way.
That case is part of a bigger shift in liver and rare disease care right now:
Base or prime editing moving from lab to bedside for hemophilia, metabolic disorders
AI catching fatty liver disease earlier and personalizing treatment
Liver organoids letting researchers test therapies before they reach a patient
The liver’s biology making it a prime target for next gen gene therapy
‘Rare disease’ used to mean ‘no good options.’ That’s changing fast.
What’s the most exciting thing you’ve seen in this space lately?
Sources:
NIH, NCATS, Baby KJ story:
Jackson Laboratory, gene editing for rare liver disorder”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience